Article -> Article Details
Title | Esoteric Testing Market Key companies Profile, their market Share and Growth Insights to 2023 |
---|---|
Category | Fitness Health --> Conferences |
Meta Keywords | Esoteric Testing Market |
Owner | vinit |
Description | |
Esoteric Testing Market – Highlights Factors such as the increasing prevalence of chronic
diseases and rising therapeutics demand are estimated to drive the market
growth during the forecast period. Additionally, advancements in diagnostic and
treatment technologies boost the market. Furthermore, esoteric testing is
generally outsourced from reference laboratories or independent laboratories
and is not cost-effective. However, low awareness and lack of healthcare services in
the middle and low-income countries are estimated to restrain the market growth
during the projected period. Regional Analysis The Americas dominates the global esoteric
testing market owing to the increasing prevalence of chronic
diseases and presence of a well-developed healthcare sector within the region.
Moreover, the increasing healthcare expenditure, growing geriatric population,
and presence of key players within the regional boundaries provide a favorable
background for the market growth. Competitive Analysis: Some of the key players in this market are LabCorp (U.S.),
Quest Diagnostics (U.S.), Invitae (U.S.), Spectra Laboratories (U.S.), Opko
Health (U.S.), Miraca Holdings (Japan), Foundation Medicine (U.S.), ACM Global
Laboratories (U.S.), Arup Laboratories (U.S.), Myriad Genetics (U.S.), Sonic
Healthcare (Australia), Primary Health Care (Australia), Healthscope
(Australia), Mayo Medical Laboratories (U.S.), Fulgent Genetics (U.S.), and
others. Europe is the second largest in the global esoteric testing
market. Factors such as the increasing availability of funds for research and a
huge patient population followed by a well-developed healthcare sector drive
the market within the region. Asia Pacific is estimated to be the fastest growing market
for esoteric testing. This can be attributed to the presence of developing
economies such as India and China and the increasing patient population.
Moreover, the increasing healthcare expenditure and a rapidly developing
healthcare sector boost the market growth within the region. On the other hand, the Middle East and Africa has the least
share in the global esoteric testing market due to the low per capita
healthcare expenditure and stringent government policies, especially within the
African region. It is estimated that the Middle East holds a majority of the
market within the Middle Eastern and African region. Segmentation: The global esoteric testing market is segmented on the basis
of test type, technology, end-user, and region. Considering test type, the
market is segmented into infectious diseases testing, endocrinology testing,
oncology testing, genetic testing, toxicology testing, immunology testing,
neurology testing, and others. By technology, the market is segmented into
chemiluminescence immunoassay, enzyme-linked immunosorbent assay, mass
spectrometry, real-time PCR, flow cytometry, radioimmunoassay, and others. By
end-user, the market is segmented into independent and reference laboratories,
research laboratories, and others. Based on region the market is segmented into
Americas, Europe, Asia Pacific, and the Middle East and Africa. 1 Report Prologue 2 Market Introduction 2.1 Definition 2.2 Scope Of The Study 2.2.1 Research Objective 2.2.2 Assumptions 2.2.3 Limitations 3 Research Methodology 3.1 Introduction 3.2 Primary Research 3.3 Secondary Research 3.4 Market Size Estimation 4 Market Dynamics 4.1 Drivers 4.2 Restraints 4.3 Opportunities 4.4 Challenges 4.5 Macroeconomic Indicators 4.6 Technology Trends & Assessment 5 Market Factor Analysis However, low awareness and lack of healthcare services in
the middle and low-income countries are estimated to restrain the market growth
during the projected period. |